Philadelphia, PA (PressExposure) March 20, 2012 -- The '2nd Annual State of Clinical Development Cost Conference' hosted by USciences and sponsored by TTC will highlight a variety of detailed research throughout this two day event. Are you interested in learning new and fascinating facts about site start-up costs in clinical trial agreements?
Based upon the GrantPlan database, whose subscribers conduct over 76% of all commercial clinical trials, TTC will examine the extent to which site start-up costs are part of the clinical trial agreements. In addition there will be a presentation that assesses the costs of the key elements often found in start-up agreements.
Along with learning which start-up costs are key, there will be other research topics addressed as well. These issues include an analysis on total site spending on key geographies, why Latin American and Asia/Pacific investigators take part in clinical trials, to how much CROs are used and how they are involved in key clinical trial activities, and the extent to which sites currently include Standard of Care considerations the in clinical trial budgeting.
Don't miss the opportunity to get the most up-to-date data on these topics. If you would like to register for the conference please visit the conference website at http://www.stateofclindev.com or if you have any questions please email firstname.lastname@example.org.
Harold Glass, TTC Principal, and USciences Professor, summed up the upcoming conference as, "The'2nd Annual State of Clinical Development Cost' will focus on managing clinical development costs based on current industry trends, improving ROI, and increasing compliance. We are bringing together some of the best thinkers in the industry and academia for two days of notable keynote addresses, one-on-one talks, and panel discussions that covered the most up-to-date empirical research and experiences of leading edge companies."
For more information on Clinical Trials visit http://www.ttc-llc.com or call us at +1-215.243.4103